Principal Financial Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27M | Buy |
50,982
+540
| +1% | +$249K | 0.01% | 814 |
|
|
2026
Q1 | $24.2M | Buy |
50,442
+2,740
| +6% | +$1.4M | 0.01% | 810 |
|
|
2025
Q4 | $26.8M | Sell |
47,702
-1,435
| -3% | -$815K | 0.01% | 728 |
|
|
2025
Q3 | $25.3M | Sell |
49,137
-4,509
| -8% | -$1.97M | 0.01% | 737 |
|
|
2025
Q2 | $16.8M | Sell |
53,646
-4,290
| -7% | -$1.29M | 0.01% | 941 |
|
|
2025
Q1 | $17.7M | Sell |
57,936
-1,322
| -2% | -$445K | 0.01% | 911 |
|
|
2024
Q4 | $19.7M | Sell |
59,258
-181
| -0.3% | -$61.4K | 0.01% | 857 |
|
|
2024
Q3 | $19.8M | Sell |
59,439
-19,439
| -25% | -$7.38M | 0.01% | 848 |
|
|
2024
Q2 | $32.5M | Sell |
78,878
-9,311
| -11% | -$3.69M | 0.02% | 609 |
|
|
2024
Q1 | $35.6M | Sell |
88,189
-12,732
| -13% | -$4.48M | 0.02% | 604 |
|
|
2023
Q4 | $30.9M | Buy |
100,921
+3,808
| +4% | +$1.03M | 0.02% | 621 |
|
|
2023
Q3 | $23.5M | Sell |
97,113
-3,173
| -3% | -$812K | 0.02% | 723 |
|
|
2023
Q2 | $24.1M | Sell |
100,286
-6,165
| -6% | -$1.28M | 0.02% | 731 |
|
|
2023
Q1 | $20M | Sell |
106,451
-745
| -0.7% | -$154K | 0.01% | 850 |
|
|
2022
Q4 | $22.8M | Buy |
107,196
+8,406
| +9% | +$1.68M | 0.02% | 737 |
|
|
2022
Q3 | $15.5M | Sell |
98,790
-8,686
| -8% | -$1.39M | 0.01% | 931 |
|
|
2022
Q2 | $16.1M | Buy |
107,476
+7,234
| +7% | +$1.05M | 0.01% | 991 |
|
|
2022
Q1 | $16.4M | Sell |
100,242
-463
| -0.5% | -$76.3K | 0.01% | 1056 |
|
|
2021
Q4 | $21.9M | Sell |
100,705
-2,203
| -2% | -$461K | 0.01% | 890 |
|
|
2021
Q3 | $19.5M | Buy |
102,908
+4,164
| +4% | +$759K | 0.01% | 971 |
|
|
2021
Q2 | $17.4M | Buy |
98,744
+130
| +0.1% | +$22.4K | 0.01% | 1082 |
|
|
2021
Q1 | $16.2M | Buy |
98,614
+11,687
| +13% | +$1.79M | 0.01% | 1091 |
|
|
2020
Q4 | $12.1M | Sell |
86,927
-27,858
| -24% | -$3.51M | 0.01% | 1114 |
|
|
2020
Q3 | $12.8M | Sell |
114,785
-107,642
| -48% | -$12.4M | 0.01% | 915 |
|
|
2020
Q2 | $20.7M | Sell |
222,427
-8,831
| -4% | -$751K | 0.02% | 636 |
|
|
2020
Q1 | $17M | Sell |
231,258
-7,655
| -3% | -$665K | 0.02% | 623 |
|
|
2019
Q4 | $20.1M | Sell |
238,913
-6,405
| -3% | -$496K | 0.02% | 794 |
|
|
2019
Q3 | $20.6M | Buy |
245,318
+7,219
| +3% | +$545K | 0.02% | 741 |
|
|
2019
Q2 | $15.6M | Buy |
238,099
+8,666
| +4% | +$499K | 0.01% | 959 |
|
|
2019
Q1 | $13.5M | Buy |
229,433
+2,782
| +1% | +$166K | 0.01% | 1035 |
|
|
2018
Q4 | $12M | Buy |
226,651
+218,477
| +2,673% | +$12M | 0.01% | 1061 |
|
|
2018
Q3 | $490K | Buy |
8,174
+117
| +1% | +$6.4K | ﹤0.01% | 1964 |
|
|
2018
Q2 | $346K | Buy |
+8,057
| New | +$325K | ﹤0.01% | 2040 |
|
Other funds holding MEDP
WA
Principal Financial Group's MEDP Position: Q2 2026 in Review
Principal Financial Group increased its Medpace (MEDP) stake by 1.1% in Q2 2026, buying an estimated $249K and bringing the position to 50,982 shares worth $27M. The position accounts for 0.01% of the portfolio, ranked #814.
Principal Financial Group first reported a position in MEDP in Q2 2018 and has held it in 33 quarters since. The position peaked at $35.6M in Q1 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Principal Financial Group held 50,982 shares of Medpace worth $27M as of Q2 2026.
- Principal Financial Group bought 540 Medpace shares in Q2 2026, an estimated $249K.
- Medpace made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #814 holding.
- Principal Financial Group first reported a position in Medpace in Q2 2018 and has held it in 33 quarters since.
- Principal Financial Group's Medpace position peaked at $35.6M in Q1 2024.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.